Valeant’s departing CEO Michael Pearson was key force on pricing By: MarketWatch May 02, 2016 at 08:36 AM EDT Documents collected for a Senate investigation provide insight into how Valeant arrived at sharp price increases. Read More >> Related Stocks: Valeant Pharmaceuticals International, Inc.